Maven Securities LTD Buys Shares of 19,147 SPDR S&P Biotech ETF $XBI

Maven Securities LTD bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 19,147 shares of the exchange traded fund’s stock, valued at approximately $3,028,000.

A number of other institutional investors have also made changes to their positions in XBI. Angeles Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth approximately $28,000. Axiom Investment Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $26,000. Financial Life Planners acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $27,000. Finally, Morling Financial Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $36,000.

SPDR S&P Biotech ETF Stock Down 1.1%

NYSEARCA:XBI opened at $161.93 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $92.64 and a 52 week high of $169.89. The stock’s fifty day moving average is $158.37 and its two-hundred day moving average is $141.16. The stock has a market capitalization of $10.57 billion, a price-to-earnings ratio of 11.47 and a beta of 0.84.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.